Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma March 20, 2021checkorphan Learn more about: Enteropathy-associated T-cell lymphoma Related Clinical Trial Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma Recruitment InformationAdministrative Informations
